Suite of highly innovative Cannabidiol (CBD) infused pain management and beauty products available online and distributed to over 750 retail locations throughout the U.S. Featured in numerous online and print... read more →
Hemp pioneer Geoff Whaling to join Canopy Growth USA as Strategic Advisor, Hemp and CBD in addition to being the co-Founder and President of Hemp Developments LLC. SMITHS FALLS, ON, March 21, 2019 /PRNewswire/... read more →
The global conglomerate Whole Foods Market, well known for its wide organic selections and high-ticket items, seems to have a positive outlook on selling marijuana-related products in the future. The... read more →
CBD remains the talk of main street. The non-psychoactive component in Cannabis, and often referred to as the ‘sibling’ of THC, is claimed to have a myriad of health benefits... read more →
Canadian Pension Fund Loads up on These 4 Marijuana Stocks: The Public Sector Pension Investment Board (PSP) is one of Canada’s largest pension investment managers, with CDN $153 billion of net assets under management as... read more →
Canopy Growth Adds Martha Stewart as Advisor, Will Assist on New Hemp CBD Products: Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Sequential Brands Group, Inc. (NASDAQ: SQBG) announced today that Martha Stewart... read more →
Acquisition unites cannabis pioneer with leading natural food CPG company to create hemp and CBD-infused food and wellness products for North America NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or “the... read more →
VAUGHAN, Ontario, Feb. 20, 2019 /PRNewswire/ -- CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: TRST) is pleased to announce that it has satisfied all the regulatory requirements to list its common... read more →
NEW YORK, Feb. 20, 2019 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus"), (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to... read more →
Aleafia Health Patient Outcomes Point to Potential Pivot from Opioids and Benzos towards Medical Cannabis—a potential $25 Billion shift Heading into the last week of January, vertically integrated Canadian medicinal... read more →